Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
A2B covalent ligand (AC140)
Cat.#: ASSD-140
Specifications
Description A2B covalent ligand selectively targets lysine residue(s) on the receptor and binds persistently in radioligand displacement and wash-out assays, allowing for novel ways to interrogate the A2BAR. Apparent pKi values at A2BARs are 8.10 and 9.17 (after 4h), where a Ki shift indicates a covalent mode of action.
Displays ~100 -fold selectivity for A2B compared to A1, A2A and A3 receptors.Size 50 μg Chemical Name 4-(2,6-dioxo-1-propyl-2,3,6,7-tetrahydro-1H-purin-8-yl)benzenesulfonyl fluoride Molecule Weight 352.3 Molecular formula C14H13FN4O4S Purity >95% Solubility Soluble in DMSO Storage Store at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-132 Congo Red (AC132) 100 mg, 1g inquiry ASSD-148 Sulforhodamine 101 (AC148) 50 mg, 100 mg inquiry ASSD-188 Dansyl Chloride (AC188) 1 g inquiry ASSD-129 Fluorescent 5-HT1A antagonist [NAN-190] (AC129) 50 μg inquiry ASSD-212 5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate N-succinimidyl ester (AC212) 25 mg inquiry ASSD-179 8-Azidoadenosine-5′-diphosphate Sodium Salt (AC179) 1 mg, 5 mg inquiry ASSD-209 Tetramethylrhodamine isothiocyanate Isomer R (AC209) 5 mg, 10 mg inquiry ASSD-194 7-(Diethylamino)coumarin-3-carboxylic acid (AC194) 100 mg inquiry ASSD-122 Fluorescent β2 antagonist [(±)-propranolol] (AC122) 500 μg inquiry ASSD-183 5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein hydrochloride (AC183) 100 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket